Credicorp BAP 深 滬
交易中 10-08 10:52:15 美东时间
382.00
+5.890
+1.57%
華盛通- 最 高382.00
- 今 開374.33
- 成交量 1.19万股
- 最 低 373.11
- 昨 收 376.11
- 總市值 303.38亿
- 52周最高 413.245
- 市盈率 靜 15.65
- 換手率 0.01%
- 52周最低 215.9754
- 委 比 -37.50%
- 總股本 7941.93万
- 歷史最高 413.245
- 量 比 0.21
- 振 幅 2.36%
- 歷史最低 -5.6941
- 每 手 1
- 風險率 51.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Here’s How Much You Would Have Made Owning Credicorp Stock In The Last 5 Years
Credicorp (NYSE:BAP) has outperformed the market over the past 5 years by 12.12% on an annualized basis producing an average annual return of 24.49%. Currently, Credicorp has a market capitalization of $30.59 billion. Buying $1000 In BAP: If an investor had bought $1000 of BAP stock 5 years ago, it ...
10-07 07:30
$100 Invested In Credicorp 20 Years Ago Would Be Worth This Much Today
Credicorp (NYSE:BAP) has outperformed the market over the past 20 years by 2.6% on an annualized basis producing an average annual return of 11.76%. Currently, Credicorp has a market capitalization of $30.61 billion. Buying $100 In BAP: If an investor had bought $100 of BAP stock 20 years ago, it wo...
09-24 05:45
美股大行评级 | 矿业股获齐声唱多！金田、纽曼矿业等目标价均获上调；携程遭看淡至60美元，较现价仍溢价5成
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从10.25美元升至11美元；Needham：上调Rocket Pharmaceuticals"买入"评级，目标价9美元
09-17 16:16
Here’s How Much You Would Have Made Owning Credicorp Stock In The Last 20 Years
Credicorp (NYSE:BAP) has outperformed the market over the past 20 years by 2.81% on an annualized basis producing an average annual return of 11.9%. Currently, Credicorp has a market capitalization of $30.28 billion. Buying $1000 In BAP: If an investor had bought $1000 of BAP stock 20 years ago, it ...
09-17 05:01
JP Morgan Upgrades Credicorp to Overweight, Raises Price Target to $482
JP Morgan analyst Yuri Fernandes upgrades Credicorp (NYSE:BAP) from Neutral to Overweight and raises the price target from $453 to $482.
09-16 21:54
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
UBS Maintains Buy on Credicorp, Raises Price Target to $473
UBS analyst Thiago Batista maintains Credicorp (NYSE:BAP) with a Buy and raises the price target from $412 to $473.
08-20 23:38
Credicorp (BAP) Receives a Buy from UBS
In a report released today, Thiago Batista from UBS maintained a Buy rating on ...
08-20 19:17
Credicorp Q2 EPS $7.29 Beats $7.20 Estimate, Sales $1.791B Beat $1.720B Estimate
Credicorp (NYSE:BAP) reported quarterly earnings of $7.29 per share which beat the analyst consensus estimate of $7.20 by 1.25 percent. This is a 16.83 percent increase over earnings of $6.24 per share from the same period last year. The company reported quarterly sales of $1.791 billion which beat ...
08-14 05:13
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 2Q26
Credicorp Ltd. announced that its 2Q26 Earnings Release will be published on August 13, 2026, after market close. A webcast and conference call to discuss the results will be held on August 16, 2026, at 9:30 a.m. Lima time (10:30 a.m. Eastern Time). The call will feature several executives, including Gianfranco Ferrari (CEO) and Alejandro Perez Reyes (CFO). Participants can pre-register via a provided link or join by dialing specified numbers. A ...
07-31 20:15
